Advertisement
New Zealand markets close in 4 hours 13 minutes
  • NZX 50

    11,793.25
    -42.79 (-0.36%)
     
  • NZD/USD

    0.5899
    -0.0007 (-0.12%)
     
  • NZD/EUR

    0.5542
    -0.0003 (-0.05%)
     
  • ALL ORDS

    7,823.30
    -75.60 (-0.96%)
     
  • ASX 200

    7,567.60
    -74.50 (-0.97%)
     
  • OIL

    82.48
    -0.25 (-0.30%)
     
  • GOLD

    2,391.50
    -6.50 (-0.27%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • NIKKEI 225

    37,358.50
    -721.20 (-1.89%)
     
  • NZD/JPY

    91.1670
    -0.0870 (-0.10%)
     

Moderna Stock: Buy, Sell, or Hold in 2023?

Moderna Stock: Buy, Sell, or Hold in 2023?

Moderna (NASDAQ: MRNA) shares delivered top returns to investors in the earlier days of the pandemic. This year, though, the stock is heading for a 30% loss, even though Moderna's coronavirus vaccine generates billions in revenue and profit. Looking ahead to 2023, you might be wondering whether Moderna's best days are in the past -- or if this vaccine maker still presents an opportunity.